Dwarf morning glory

Last Updated: September 28, 2022

Evolvulus alsinoides is one of four herbs referred to as Shankhapushpi and is traditionally used in Ayurveda for nootropic and psychotropic effects. It appears to enhance learning in otherwise normal rodents with comparable potency to Piracetam.

dosageDosage

Dwarf morning glory is most often used for

Summary

Evolvulus alsinoides is one of the four herbs that is given the common name of Shankhapushpi, and appears to be a nootropic agent with comparable potency to Piracetam in otherwise healthy young rats. The mechanisms and exact bioactives underlying these benefits are not currently known, but seem to be localized more in the ethanolic extract and are thought to be alkaloids. There is no human data on this plant at this moment in time.

Beyond the memory enhancing properties evolvulus appears to have general anti-inflammatory, adaptogenic, and neuroprotective properties in the brain following oral ingestion and high doses may confer a sedative property. However, there is insufficient evidence to compare the efficacy of evolvulus against other herbs to see if a role for this herb exists or not. The lack of known bioactive limits research on it.

What else is Dwarf morning glory known as?
Note that Dwarf morning glory is also known as:
  • Dwarf Morning Glory
  • Shankhapushpi
  • Evolvulus Alsinoides
Dwarf morning glory should not be confused with:
Dosage information

There is insufficient evidence in humans to recommend an ideal dose, but the estimated effective dose in rats (200mg/kg) correlates to approximately 32mg/kg of the ethanolic extract in humans and thus:

  • 2,200mg for a 150lb person
  • 2,900mg for a 200lb person
  • 3,600mg for a 250lb person

These dosages for an ethanolic extract of evolvulus alsinoides are but estimates based on the animal research.

Don't miss out on the latest research

Research Breakdown

🚧 Under Renovation 🚧

The information in this section is slated for renovation — it will soon be transformed into a more usable (and readable!) form in the coming months. As such, the text in this section may be out of date and not up to Examine’s current standards for writing style.